← Leaderboards
Charles Chavkin
University Of Washington
$29,473,455
Attributed
$29,473,455
Total exposure
22
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,307,639 · 25
By mechanism
P30$18,899,683 · 8
P50$10,968,142 · 4
R01$6,580,287 · 4
P01$5,446,170 · 2
T32$5,330,534 · 1
R37$2,480,683 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Benjamin Ross$2,624,869
- Sridhar Mani$6,137,733
- Paul E. M. Phillips$15,934,032
- Joseph David Mougous$10,581,472
- Michael R Bruchas$23,108,955
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularStressTrainingNeuronsBehavioralNeural CircuitOpioidDesignBrainDynorphinsIn VivoAddictionBaseWashingtonUniversitiesMediatingResearch PersonnelPostdoctoral FellowOpioid ReceptorResponseFundingResourcesGraduate StudentInsight
Grant awards (138)
University of Washington Center of Excellence in Opioid Addiction Research$1,598,795
P30 · FY2025 · DA · contact PI
Administrative Core$467,430
P30 · FY2025 · DA · contact PI
Pilot Project Core$127,684
P30 · FY2025 · DA · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,599,427
P30 · FY2024 · DA · contact PI
Administrative Core$452,502
P30 · FY2024 · DA · contact PI
Pilot Project Core$127,684
P30 · FY2024 · DA · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,327,602
P30 · FY2023 · DA · contact PI
Imaging and Neural Circuits Core$520,283
P30 · FY2023 · DA · contact PI
Molecular Genetics Resource Core$419,139
P30 · FY2023 · DA · contact PI
Admin Core$252,492
P30 · FY2023 · DA · contact PI
Pilot Project Core$135,688
P30 · FY2023 · DA · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,324,877
P30 · FY2022 · DA · contact PI
Imaging and Neural Circuits Core$490,534
P30 · FY2022 · DA · contact PI
Molecular Genetics Resource Core$447,129
P30 · FY2022 · DA · contact PI
Cellular and Circuit Mechanisms Responsible for Dynorphin Actions in mPFC$388,750
R56 · FY2022 · DA · contact PI
Admin Core$251,526
P30 · FY2022 · DA · contact PI
Pilot Project Core$135,688
P30 · FY2022 · DA · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,323,929
P30 · FY2021 · DA · contact PI
Imaging and Neural Circuits Core$490,534
P30 · FY2021 · DA · contact PI
Molecular Genetics Resource Core$447,129
P30 · FY2021 · DA · contact PI
Admin Core$250,578
P30 · FY2021 · DA · contact PI
Pilot Project Core$135,688
P30 · FY2021 · DA · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,315,065
P30 · FY2020 · DA · contact PI
Molecular Genetics Resource Core$477,023
P30 · FY2020 · DA · contact PI
Imaging and Neural Circuits Core$452,705
P30 · FY2020 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Behaviors$340,898
R01 · FY2020 · DA · contact PI
Admin Core$249,649
P30 · FY2020 · DA · contact PI
Pilot Project Core$135,688
P30 · FY2020 · DA · contact PI
Stress Mechanisms Increasing Risk of Mood-Disorders$1,500,907
P50 · FY2019 · MH · contact PI
University of Washington Center of Excellence in Opioid Addiction Research$1,276,358
P30 · FY2019 · DA · contact PI
Molecular Genetics Resource Core$456,318
P30 · FY2019 · DA · contact PI
Imaging and Neural Circuits Core$395,318
P30 · FY2019 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Behaviors$341,074
R01 · FY2019 · DA · contact PI
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic Depression$321,914
P50 · FY2019 · MH · contact PI
Admin Core$262,613
P30 · FY2019 · DA · contact PI
Research Support Core$199,721
P50 · FY2019 · MH · contact PI
Pilot Project Core$162,109
P30 · FY2019 · DA · contact PI
Administrative Core$110,088
P50 · FY2019 · MH · contact PI
Therapeutic Potential of Kappa Opioids$25,000
R13 · FY2019 · DA · contact PI
Stress Mechanisms Increasing Risk of Mood-Disorders$1,472,288
P50 · FY2018 · MH · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Behaviors$341,246
R01 · FY2018 · DA · contact PI
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic Depression$321,915
P50 · FY2018 · MH · contact PI
Training in the Molecular Pharmacology of Abused Drugs$307,411
T32 · FY2018 · DA · contact PI
Research Support Core$199,721
P50 · FY2018 · MH · contact PI
Administrative Core$110,088
P50 · FY2018 · MH · contact PI
Therapeutic Potential of Kappa Opioids$1
R13 · FY2018 · DA · contact PI
Stress Mechanisms Increasing Risk of Mood-Disorders$1,483,534
P50 · FY2017 · MH · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Behaviors$340,454
R01 · FY2017 · DA · contact PI
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic Depression$321,915
P50 · FY2017 · MH · contact PI
Training in the Molecular Pharmacology of Abused Drugs$299,895
T32 · FY2017 · DA · contact PI
Research Support Core$199,721
P50 · FY2017 · MH · contact PI
Administrative Core$110,088
P50 · FY2017 · MH · contact PI
Therapeutic Potential of Kappa Opioids$25,000
R13 · FY2017 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$7,167
T32 · FY2017 · DA · contact PI
Stress Mechanisms Increasing Risk of Mood-Disorders$1,526,661
P50 · FY2016 · MH · contact PI
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic Depression$321,915
P50 · FY2016 · MH · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Behaviors$314,779
R01 · FY2016 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$291,769
T32 · FY2016 · DA · contact PI
Research Support Core$199,721
P50 · FY2016 · MH · contact PI
Administrative Core$110,088
P50 · FY2016 · MH · contact PI
Therapeutic Potential of Kappa Opioids$1
R13 · FY2016 · DA · contact PI
Stress Mechanisms Increasing Risk of Mood-Disorders$1,638,571
P50 · FY2015 · MH · contact PI
Training in the Molecular Pharmacology of Abused Drugs$484,843
T32 · FY2015 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion$309,349
R01 · FY2015 · DA · contact PI
Administrative Core$273,096
P50 · FY2015 · MH · contact PI
Therapeutic Potential of Kappa Antagonists in the Adjunctive Treatment of Psychotic Depression$273,096
P50 · FY2015 · MH · contact PI
Research Support Core$273,094
P50 · FY2015 · MH · contact PI
Mechanism of Stress-induced Translocation of the Serotonin Transporter$193,125
R21 · FY2015 · MH · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$122,278
K05 · FY2015 · DA · contact PI
Therapeutic Potential of Kappa Opioids$25,000
R13 · FY2015 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion$314,569
R01 · FY2014 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$272,905
T32 · FY2014 · DA · contact PI
Mechanism of Stress-induced Translocation of the Serotonin Transporter$231,750
R21 · FY2014 · MH · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$122,278
K05 · FY2014 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$94,632
T32 · FY2014 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$94,632
T32 · FY2014 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion$302,460
R01 · FY2013 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$264,945
T32 · FY2013 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$241,302
R37 · FY2013 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$122,278
K05 · FY2013 · DA · contact PI
Therapeutic Potential of Kappa Opioids$25,000
R13 · FY2013 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$346,485
T32 · FY2012 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion$315,541
R01 · FY2012 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$251,356
R37 · FY2012 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$122,278
K05 · FY2012 · DA · contact PI
p38 MAPK Mechanisms of Kappa Opioid-Induced Aversion$316,992
R01 · FY2011 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$261,057
T32 · FY2011 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$251,356
R37 · FY2011 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$122,278
K05 · FY2011 · DA · contact PI
Therapeutic Potential of Kappa Opioids$25,000
R13 · FY2011 · DA · contact PI
New Faculty Search for Functional Proteomic Approaches to Drug Abuse$700,547
P30 · FY2010 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$259,130
R37 · FY2010 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$255,459
T32 · FY2010 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$120,334
K05 · FY2010 · DA · contact PI
New Faculty Search for Functional Proteomic Approaches to Drug Abuse$689,952
P30 · FY2009 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$261,747
R37 · FY2009 · DA · contact PI
Training in the Molecular Pharmacology of Abused Drugs$250,041
T32 · FY2009 · DA · contact PI
The Role of Kappa Opioid Receptor-induced Activation of Astrocytes in the Reinsta$234,000
R21 · FY2009 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$120,334
K05 · FY2009 · DA · contact PI
The Role of Kappa Opioid Receptor-induced Activation of Astrocytes in the Reinsta$21,453
R21 · FY2009 · DA · contact PI
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$247,022
T32 · FY2008 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$224,712
R37 · FY2008 · DA · contact PI
The Role of Kappa Opioid Receptor-induced Activation of Astrocytes in the Reinsta$195,000
R21 · FY2008 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$120,334
K05 · FY2008 · DA · contact PI
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$247,022
T32 · FY2007 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$229,298
R37 · FY2007 · DA · contact PI
Opioid mediation of stress-potentiated cocaine response$229,298
R01 · FY2007 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$120,334
K05 · FY2007 · DA · contact PI
Molecular Components Underlying Drug Abuse$1,081,408
P01 · FY2006 · DA · contact PI
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$249,487
T32 · FY2006 · DA · contact PI
Regulation of Opioid Signaling by Tyr-Phosphorylation$247,605
R37 · FY2006 · DA · contact PI
Opioid mediation of stress-potentiated cocaine response$245,695
R01 · FY2006 · DA · contact PI
Dynorphins and Kappa Opioid Receptors in the Stress Response$120,334
K05 · FY2006 · DA · contact PI
Molecular Components Underlying Drug Abuse$1,133,621
P01 · FY2005 · DA
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$269,034
T32 · FY2005 · DA
Regulation of Opioid Signaling by Tyr-Phosphorylation$265,300
R37 · FY2005 · DA
Opioid mediation of stress-potentiated cocaine response$265,300
R01 · FY2005 · DA
Molecular Components Underlying Drug Abuse$1,100,684
P01 · FY2004 · DA
Opioid mediation of stress-potentiated cocaine response$265,300
R01 · FY2004 · DA
TRAINING IN THE MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$252,260
T32 · FY2004 · DA
Regulation of Opioid Signaling by Tyr-Phosphorylation$248,877
R37 · FY2004 · DA
ENDOGENOUS OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS$241,143
R01 · FY2004 · DA
Molecular Components Underlying Drug Abuse$1,057,434
P01 · FY2003 · DA
Opioid mediation of stress-potentiated cocaine response$290,300
R01 · FY2003 · DA
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMS$235,670
R01 · FY2003 · DA
ENDOGENOUS OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS$234,120
R01 · FY2003 · DA
TRAINING IN MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$215,981
T32 · FY2003 · DA
Molecular Components Underlying Drug Abuse$1,073,023
P01 · FY2002 · DA
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMS$228,805
R01 · FY2002 · DA
ENDOGENOUS OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS$227,303
R01 · FY2002 · DA
TRAINING IN MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$216,757
T32 · FY2002 · DA
COMPONENTS UNDERLYING OPIOID RECEPTOR TOLERANCE$0
P01 · FY2002 · DA
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMS$222,143
R01 · FY2001 · DA
ENDOGENOUS OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS$220,680
R01 · FY2001 · DA
TRAINING IN MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$209,148
T32 · FY2001 · DA
ENDOGENOUS OPIOID PEPTIDE ACTION IN THE HIPPOCAMPUS$221,494
R01 · FY2000 · DA
MODELS OF OPIOID RECEPTOR DESENSITIZATION MECHANISMS$215,674
R01 · FY2000 · DA
TRAINING IN MOLECULAR PHARMACOLOGY OF ABUSED DRUGS$192,582
T32 · FY2000 · DA